Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Nusantara Inti Corpora Tbk (UNIT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Nusantara Inti Corpora Tbk: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Nusantara Inti Corpora Tbk diperdagangkan di Rp316 (kapitalisasi pasar 23,83 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 4,4× kapitalisasi pasar Nusantara Inti Corpora Tbk. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | UNIT | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 23,83 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Nusantara Inti Corpora Tbk
Established in Jakarta on 1988 named PT. Aneka Keloladana. On July 2001 changed the name to PT. United Capital Indonesia. Beside as broker dealer in Capital Market, the corporate also provide the services such as financial advisory, research. Average employees are 28 staffs.On July 06 2007, PT United Capital Indonesia Tbk has changed its name as PT Nusantara Inti Corpora Tbk.
Selengkapnya di halaman UNIT →
